Literature DB >> 10819529

The role of stroma in breast carcinoma growth in vivo.

A Noël1, J M Foidart.   

Abstract

The malignant progression of tumors is thought to be related to the expression of oncogenes and loss of expression of tumor suppressor gene. These factors are intrinsic to the cancer cells themselves. However, carcinomas are also infiltrated by host cells (fibroblasts, endothelial cells, inflammatory cells) and surrounded by an extracellular matrix which is extensively remodeled. The extracellular matrix components and infiltrating host cells provide a microenvironment that conditions both tumor progression and the metastatic process. Transplantation of human tumors into athymic nude mice has become an important experimental approach to study the biology of human cancers. The different models developed so far are beginning to elucidate the role of matrix molecules, growth factors and enzymes as well as fibroblasts in tumor progression. These animal models are likely to provide a useful tool to evaluate new antitumor treatments.

Entities:  

Mesh:

Year:  1998        PMID: 10819529     DOI: 10.1023/a:1018703208453

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  64 in total

Review 1.  The role of basement membrane in angiogenesis and tumor growth.

Authors:  D S Grant; M C Kibbey; J L Kinsella; M C Cid; H K Kleinman
Journal:  Pathol Res Pract       Date:  1994-10       Impact factor: 3.250

2.  Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties.

Authors:  A Lochter; A Srebrow; C J Sympson; N Terracio; Z Werb; M J Bissell
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

Review 3.  Endothelial differentiation using Matrigel (review).

Authors:  S Baatout
Journal:  Anticancer Res       Date:  1997 Jan-Feb       Impact factor: 2.480

Review 4.  New directions in breast cancer research.

Authors:  S R Wolman; G H Heppner; E Wolman
Journal:  FASEB J       Date:  1997-06       Impact factor: 5.191

Review 5.  The multiple roles of tumour stroma.

Authors:  N Wernert
Journal:  Virchows Arch       Date:  1997-06       Impact factor: 4.064

Review 6.  Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

Authors:  H Kosmehl; A Berndt; D Katenkamp
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

7.  Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.

Authors:  A B Undén; B Sandstedt; K Bruce; M Hedblad; M Stahle-Bäckdahl
Journal:  J Invest Dermatol       Date:  1996-08       Impact factor: 8.551

Review 8.  Breast cancer angiogenesis--new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting.

Authors:  A L Harris; H Zhang; A Moghaddam; S Fox; P Scott; A Pattison; K Gatter; I Stratford; R Bicknell
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis.

Authors:  N Brünner; E W Thompson; M Spang-Thomsen; J Rygaard; K Danø; J A Zwiebel
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

10.  Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenicity.

Authors:  R D Bonfil; A Vinyals; O D Bustuoabad; A Llorens; F J Benavides; M Gonzalez-Garrigues; A Fabra
Journal:  Int J Cancer       Date:  1994-07-15       Impact factor: 7.396

View more
  17 in total

Review 1.  Hedgehog signaling in mouse mammary gland development and neoplasia.

Authors:  M T Lewis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 2.  A visual-quantitative analysis of fibroblastic stromagenesis in breast cancer progression.

Authors:  Edna Cukierman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

3.  Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues.

Authors:  M R D'Andrea; C K Derian; R J Santulli; P Andrade-Gordon
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

4.  There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.

Authors:  H Chauhan; A Abraham; J R A Phillips; J H Pringle; R A Walker; J L Jones
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

5.  Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms.

Authors:  Olga Zolochevska; Marxa L Figueiredo
Journal:  Oral Oncol       Date:  2009-06-09       Impact factor: 5.337

Review 6.  Breast cancer progression: insights into multifaceted matrix metalloproteinases.

Authors:  Vincent Chabottaux; Agnès Noel
Journal:  Clin Exp Metastasis       Date:  2007-10-30       Impact factor: 5.150

7.  Transcriptome analysis of epithelial and stromal contributions to mammogenesis in three week prepartum cows.

Authors:  Theresa Casey; Heather Dover; James Liesman; Lindsey DeVries; Matti Kiupel; Michael Vandehaar; Karen Plaut
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

8.  Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors.

Authors:  Stephanie C Lebret; Donald F Newgreen; Erik W Thompson; M Leigh Ackland
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

Review 9.  Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.

Authors:  S L Schor; A M Schor
Journal:  Breast Cancer Res       Date:  2001-09-06       Impact factor: 6.466

10.  Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats.

Authors:  Milena Durando; Laura Kass; Julio Piva; Carlos Sonnenschein; Ana M Soto; Enrique H Luque; Mónica Muñoz-de-Toro
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.